跳至主要内容
临床试验/CTRI/2025/07/090110
CTRI/2025/07/090110尚未招募不适用

A Prospective Observational study on Prognostic ability of Hematocrit to Albumin ratio in Acute Pancreatitis Patient

DrArjun MH1 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
173
试验地点
1
主要终点
Determine the relationship between Hematocrit to albumin ratio and severity of acute pancreatitis

研究概览

简要总结

A Prospective Observational Study on Evaluating the Significance of the Hematocrit-to-Albumin Ratio in Predicting the Severity, Complications, and Prognosis of Acute Pancreatitis. The purpose of this study is to provide and simplify scoring systems for the prognosis of acute pancreatitis. The study is done between August 2025 to March 2027. Informed consent will be obtained from all willing participants, with minimal risk involved. For patients eligible under the inclusion criteria, the hematocrit-to-albumin values will be obtained. These investigations are routine and commonly investigated parameters. The hematocrit-to-albumin ratio shall be calculated and divided into two groups of high risk and low risk and shall be followed up to discharge. Sensitivity and specificity shall be calculated using the area under the curve, which helps to determine the relationship between the hematocrit-to-albumin ratio and the severity of acute pancreatitis

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patient diagnosed with acute pancreatitis based on the 2012 revised Atlanta Classification Patient who provide informed consent to participate in the study.

排除标准

  • Patient diagnosed with acute pancreatitis with significant unrelated complication (e.g. Nephrotic syndrome, CLD) Patient with severe life threatening conditions (e.g.CKD STAGE 5,Malignancy) Patient diagnosed with chronic pancreatitis or a history of recurrent pancreatitis.

结局指标

主要结局

Determine the relationship between Hematocrit to albumin ratio and severity of acute pancreatitis

时间窗: 1 years and 7 months

次要结局

  • Asses hematocrit to albumin ratio are associated with clinical outcomes, including complications and mortality rate.(1 years 7 months)
  • Analyze the incidence of complications(e.g., necrosis, infection, organ failure)in relation to the hematocrit to albumin ratio and insight their roles as potential biomarkers for complications.(1 year 7 months)

研究者

发起方
DrArjun MH
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Arjun MH

Kasturba Medical College

研究点 (1)

Loading locations...

相似试验

Prognostic ability of Hematocrit to Albumin ratio in... | 临床试验